MEA Vagus Nerve Stimulation Market - Industry Trends and Forecast to 2029

MEA Vagus Nerve Stimulation Market - Industry Trends and Forecast to 2029

Middle East and Africa vagus nerve stimulation market is projected to register a substantial CAGR of 4.1% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029.

Market Segmentation

Middle East and Africa Vagus Nerve Stimulation Market, By Product Type (Implantable VNS Devices and External VNS Devices), Biomaterial (Ceramics, Metallic, and Polymerics), Application (Pain Management, Epileptic Seizures, Obesity Management, Depression and Anxiety, and Others), Patient Type (Adults, Pediatric, and Geriatric), End User (Hospitals, Ambulatory Surgical Centers, Specialty Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (UAE, Israel, South Africa, Saudi Arabia, Egypt, and Rest of Middle East and Africa) Industry Trends and Forecast to 2029

Some of the major factors contributing to the growth of the Middle East and Africa vagus nerve stimulation market are:
• Increasing prevalence and incidence of neurological disorders
• Innovative non-invasive Vagus Nerve Stimulation (nVNS) devices introduced to meet the demand
• Rise in product approvals
• Product development in recent years

Market Players

Some of the key market players in the Middle East and Africa vagus nerve stimulation market are listed below:
• Medtronic
• SetPoint Medical
• tVNS Technologies GmbH
• MicroTransponder Inc.
• Parasym Ltd
• ReShape Lifesciences, Inc.
• Others

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.